Atezolizumab (SCLC): Solution concentrate for I.V. infusion 840 mg in 14 ml; Tecentriq® Page last updated: 3 July 2020 Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB) Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)